|
USP5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.104700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.575870E-02 |
| Normal-vs-Stage2 |
1.815280E-03 |
| Normal-vs-Stage3 |
1.568200E-02 |
| Normal-vs-Stage4 |
9.870400E-01 |
| Stage1-vs-Stage2 |
1.273770E-01 |
| Stage1-vs-Stage3 |
6.208800E-01 |
| Stage1-vs-Stage4 |
3.824200E-02 |
| Stage2-vs-Stage3 |
4.243400E-01 |
| Stage2-vs-Stage4 |
8.797800E-03 |
| Stage3-vs-Stage4 |
3.790500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.895300E-03 |
| Normal-vs-AfricanAmerican |
1.355020E-01 |
| Normal-vs-Asian |
9.187400E-01 |
| Caucasian-vs-AfricanAmerican |
6.887800E-01 |
| Caucasian-vs-Asian |
3.960800E-01 |
| AfricanAmerican-vs-Asian |
4.594600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.095700E-03 |
| Normal-vs-Female |
1.414370E-01 |
| Male-vs-Female |
9.128100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.764300E-03 |
| Normal-vs-Age(41-60Yrs) |
9.657100E-03 |
| Normal-vs-Age(61-80Yrs) |
5.213600E-02 |
| Normal-vs-Age(81-100Yrs) |
9.202200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.415600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.575790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.285000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.569400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.723600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.506600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.747430E-01 |
| Normal-vs-Grade 2 |
2.479700E-03 |
| Normal-vs-Grade 3 |
3.050100E-02 |
| Normal-vs-Grade 4 |
8.927000E-01 |
| Grade 1-vs-Grade 2 |
7.949400E-01 |
| Grade 1-vs-Grade 3 |
8.271200E-01 |
| Grade 1-vs-Grade 4 |
2.112000E-01 |
| Grade 2-vs-Grade 3 |
2.701800E-01 |
| Grade 2-vs-Grade 4 |
1.827550E-02 |
| Grade 3-vs-Grade 4 |
1.095390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.540300E-03 |
| Normal-vs-ccB subtype |
1.235740E-02 |
| ccA subtype-vs-ccB subtype |
7.272000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.524000E-02 |
| Normal-vs-N1 |
9.968100E-02 |
| N0-vs-N1 |
9.242500E-03 |
|
|
